| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.2 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.2 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |